Novo Continues Manufacturing Spending Spree with $400M Denmark Expansion, $200M Plant Purchase

In recent months Novo Nordisk has invested several billions of dollars to boost its manufacturing capacity—including its highly contested $16.5 billion merger with CDMO giant Catalent.